{"entity":{"type":"insider","cik":"0001401304","url":"/insider/0001401304","json_url":"/insider/0001401304.json","name":"Palling David","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":29,"n_filings":14,"first":"2008-02-05","last":"2009-06-30","span_basis":"filed_date"},"name_variants":[{"name":"Palling David","source":"filing","n_filings":14,"first_seen":"2008-02-05","last_seen":"2009-06-30"}],"transactions":[{"id":5719643,"accession":"0001209191-09-034166","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-034166","line_url":"/filing/0001209191-09-034166#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401304","owner_name":"Palling David","owner_display_name":"Palling David","owner_url":"/insider/0001401304","role":"Officer (Sr VP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (Sr VP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":10.539,"price_display":"10.54","price_state":"stated","total_value":26347.5,"total_display":"26,347.50","total_whole":"26,348","shares_owned_after":34040.0,"shares_owned_after_display":"34,040","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-06-29","filed_date":"2009-06-30","scope":"insider"},{"id":5719642,"accession":"0001209191-09-034166","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-034166","line_url":"/filing/0001209191-09-034166#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401304","owner_name":"Palling David","owner_display_name":"Palling David","owner_url":"/insider/0001401304","role":"Officer (Sr VP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (Sr VP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7498.0,"shares_display":"7,498","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":74980.0,"total_display":"74,980.00","total_whole":"74,980","shares_owned_after":36540.0,"shares_owned_after_display":"36,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-06-26","filed_date":"2009-06-30","scope":"insider"},{"id":5738266,"accession":"0001209191-09-019132","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-019132","line_url":"/filing/0001209191-09-019132#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401304","owner_name":"Palling David","owner_display_name":"Palling David","owner_url":"/insider/0001401304","role":"Officer (Sr VP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (Sr VP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2.0,"shares_display":"2","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":20.0,"total_display":"20.00","total_whole":"20","shares_owned_after":44038.0,"shares_owned_after_display":"44,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-30","filed_date":"2009-04-01","scope":"insider"},{"id":5674130,"accession":"0001209191-09-018397","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-018397","line_url":"/filing/0001209191-09-018397#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401304","owner_name":"Palling David","owner_display_name":"Palling David","owner_url":"/insider/0001401304","role":"Officer (Sr VP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (Sr VP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":531.0,"shares_display":"531","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":5310.0,"total_display":"5,310.00","total_whole":"5,310","shares_owned_after":44040.0,"shares_owned_after_display":"44,040","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-25","filed_date":"2009-03-26","scope":"insider"},{"id":5702514,"accession":"0001209191-09-018195","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-018195","line_url":"/filing/0001209191-09-018195#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401304","owner_name":"Palling David","owner_display_name":"Palling David","owner_url":"/insider/0001401304","role":"Officer (Sr VP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (Sr VP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1740.0,"shares_display":"1,740","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":17400.0,"total_display":"17,400.00","total_whole":"17,400","shares_owned_after":44571.0,"shares_owned_after_display":"44,571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-23","filed_date":"2009-03-25","scope":"insider"},{"id":5596979,"accession":"0001209191-09-017605","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-017605","line_url":"/filing/0001209191-09-017605#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401304","owner_name":"Palling David","owner_display_name":"Palling David","owner_url":"/insider/0001401304","role":"Officer (Sr VP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (Sr VP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":229.0,"shares_display":"229","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":2290.0,"total_display":"2,290.00","total_whole":"2,290","shares_owned_after":46311.0,"shares_owned_after_display":"46,311","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-19","filed_date":"2009-03-20","scope":"insider"},{"id":5783532,"accession":"0001209191-09-006844","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-006844","line_url":"/filing/0001209191-09-006844#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401304","owner_name":"Palling David","owner_display_name":"Palling David","owner_url":"/insider/0001401304","role":"Officer (Senior VP, Technical Operation)","role_mark":"O","role_mark_label":"Officer (Senior VP, Technical Operation)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP, Technical Operation","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":75000.0,"total_display":"75,000.00","total_whole":"75,000","shares_owned_after":46540.0,"shares_owned_after_display":"46,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-03","filed_date":"2009-02-05","scope":"insider"},{"id":3467172,"accession":"0001209191-08-058298","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-058298","line_url":"/filing/0001209191-08-058298#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401304","owner_name":"Palling David","owner_display_name":"Palling David","owner_url":"/insider/0001401304","role":"Officer (Senior VP, Drug Development)","role_mark":"O","role_mark_label":"Officer (Senior VP, Drug Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP, Drug Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":22000.0,"total_display":"22,000.00","total_whole":"22,000","shares_owned_after":49116.0,"shares_owned_after_display":"49,116","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-31","filed_date":"2008-11-03","scope":"insider"},{"id":3467168,"accession":"0001209191-08-058298","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-058298","line_url":"/filing/0001209191-08-058298#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401304","owner_name":"Palling David","owner_display_name":"Palling David","owner_url":"/insider/0001401304","role":"Officer (Senior VP, Drug Development)","role_mark":"O","role_mark_label":"Officer (Senior VP, Drug Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP, Drug Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":3000.0,"total_display":"3,000.00","total_whole":"3,000","shares_owned_after":51316.0,"shares_owned_after_display":"51,316","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-30","filed_date":"2008-11-03","scope":"insider"},{"id":3685123,"accession":"0001209191-08-053832","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-053832","line_url":"/filing/0001209191-08-053832","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401304","owner_name":"Palling David","owner_display_name":"Palling David","owner_url":"/insider/0001401304","role":"Officer (Senior VP, Drug Development)","role_mark":"O","role_mark_label":"Officer (Senior VP, Drug Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP, Drug Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":15.12126,"price_display":"15.12","price_state":"stated","total_value":37803.15,"total_display":"37,803.15","total_whole":"37,803","shares_owned_after":51816.0,"shares_owned_after_display":"51,816","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-29","filed_date":"2008-09-30","scope":"insider","n_lines":2},{"id":3585465,"accession":"0001209191-08-051289","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-051289","line_url":"/filing/0001209191-08-051289#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401304","owner_name":"Palling David","owner_display_name":"Palling David","owner_url":"/insider/0001401304","role":"Officer (Senior VP, Drug Development)","role_mark":"O","role_mark_label":"Officer (Senior VP, Drug Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP, Drug Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":14.832,"price_display":"14.83","price_state":"stated","total_value":44496.0,"total_display":"44,496.00","total_whole":"44,496","shares_owned_after":54116.0,"shares_owned_after_display":"54,116","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-08","filed_date":"2008-09-10","scope":"insider"},{"id":3617262,"accession":"0001209191-08-049974","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-049974","line_url":"/filing/0001209191-08-049974#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401304","owner_name":"Palling David","owner_display_name":"Palling David","owner_url":"/insider/0001401304","role":"Officer (Senior VP, Drug Development)","role_mark":"O","role_mark_label":"Officer (Senior VP, Drug Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP, Drug Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":13.77,"price_display":"13.77","price_state":"stated","total_value":34425.0,"total_display":"34,425.00","total_whole":"34,425","shares_owned_after":57116.0,"shares_owned_after_display":"57,116","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-28","filed_date":"2008-09-02","scope":"insider"},{"id":3970192,"accession":"0001209191-08-044379","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-044379","line_url":"/filing/0001209191-08-044379#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401304","owner_name":"Palling David","owner_display_name":"Palling David","owner_url":"/insider/0001401304","role":"Officer (Senior VP, Drug Development)","role_mark":"O","role_mark_label":"Officer (Senior VP, Drug Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP, Drug Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":15.077,"price_display":"15.08","price_state":"stated","total_value":37692.5,"total_display":"37,692.50","total_whole":"37,693","shares_owned_after":59616.0,"shares_owned_after_display":"59,616","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-28","filed_date":"2008-07-30","scope":"insider"},{"id":3745639,"accession":"0001209191-08-022509","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-08-022509","line_url":"/filing/0001209191-08-022509","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401304","owner_name":"Palling David","owner_display_name":"Palling David","owner_url":"/insider/0001401304","role":"Officer (Senior VP, Drug Development)","role_mark":"O","role_mark_label":"Officer (Senior VP, Drug Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP, Drug Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":11.082584,"price_display":"11.08","price_state":"stated","total_value":13853.23,"total_display":"13,853.23","total_whole":"13,853","shares_owned_after":42818.0,"shares_owned_after_display":"42,818","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-04-01","filed_date":"2008-04-03","scope":"insider","n_lines":7},{"id":3936296,"accession":"0001209191-08-015026","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-08-015026","line_url":"/filing/0001209191-08-015026","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401304","owner_name":"Palling David","owner_display_name":"Palling David","owner_url":"/insider/0001401304","role":"Officer (Senior VP, Drug Development)","role_mark":"O","role_mark_label":"Officer (Senior VP, Drug Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP, Drug Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":10.498868,"price_display":"10.50","price_state":"stated","total_value":26247.17,"total_display":"26,247.17","total_whole":"26,247","shares_owned_after":43566.0,"shares_owned_after_display":"43,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-28","filed_date":"2008-03-03","scope":"insider","n_lines":7},{"id":3887846,"accession":"0001209191-08-007807","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-007807","line_url":"/filing/0001209191-08-007807#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001401304","owner_name":"Palling David","owner_display_name":"Palling David","owner_url":"/insider/0001401304","role":"Officer (Senior VP, Drug Development)","role_mark":"O","role_mark_label":"Officer (Senior VP, Drug Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP, Drug Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":30000.0,"total_display":"30,000.00","total_whole":"30,000","shares_owned_after":45866.0,"shares_owned_after_display":"45,866","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-01","filed_date":"2008-02-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":29,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":29,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":29},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001178879","name":"AMICUS THERAPEUTICS INC","url":"/issuer/0001178879","role":"Officer (Sr VP, Technical Operations)","n_filings":14,"first_seen":"2008-02-05","last_seen":"2009-06-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001401304","retrieved_at":"2026-08-22T11:32:33+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}